Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

The Prognostic Value for Survival of Self-Reported Fatigue in Patients with Newly Diagnosed Myelodysplastic Syndromes: An International Prospective Observational Study By the Gimema

Blood (2024) 144 (Supplement 1): 404.

https://doi.org/10.1182/blood-2024-204633

Published: 2024

Journal Articles

Clinical Relevance of Individual Response to Iron Chelation Therapy (ICT) in Patients with Myelodysplastic Syndromes (MDS) and Transfusion Requirement

Blood (2019) 134 (Supplement_1): 3010.

https://doi.org/10.1182/blood-2019-129902

Published: 2019

Journal Articles

Clinical Significance of Occult Central Nervous System Disease in Adult ACUTE Lymphoblastic Leukemia. a Multicenter,Report from the Campus ALL/Gimema Network

Blood (2018) 132 (Supplement 1): 658.

https://doi.org/10.1182/blood-2018-99-114177

Published: 2018

Journal Articles

Pretreatment Health-Related Quality of Life Profile According to the EORTC QLQ-C30 in Patients with Myelodysplastic Syndromes (MDS): Analysis on 443 Lower-Risk MDS Patients

Blood (2018) 132 (Supplement 1): 2293.

https://doi.org/10.1182/blood-2018-99-110921

Published: 2018

Journal Articles

Response to Erythropoietin in Different Karyotipic Subsets of Myelodysplastic Syndromes (MDS) and MDS with Sideroblasts: Multicentric Real-Life Experience from the Grom-L Cooperative Group

Blood (2017) 130 (Supplement 1): 4262.

https://doi.org/10.1182/blood.V130.Suppl_1.4262.4262

Published: 2017

Journal Articles

Is Deferasirox Safe and Effective in Very Elderly Patients (> 75 Years) with Myelodysplastic Syndromes and Transfusional Iron Overload?

Roberto Latagliata, Pasquale Niscola, MD, Antonio Volpe, MD, Claudia Baratè, MD PhD, Alessia Campagna, MD, Antonella Poloni, PhD MD, Chiara Sarlo, MD, Laura Faglioni, MD, Daniela De Benedictis, MD, Ida Carmosino, Susanna Fenu, Maria Antonietta Aloe Spiriti, MD, Sara Galimberti, PhD MD, Massimo Breccia, MD PhD, Robin Foà, MD, Carlo Finelli, MD

Blood (2017) 130 (Supplement 1): 4263.

https://doi.org/10.1182/blood.V130.Suppl_1.4263.4263

Published: 2017

Journal Articles

Pattern of Central Nervous System (CNS) Involvement in Adult Acute Myeloid Leukemia (AML) and Its Impact on Outcome

Blood (2016) 128 (22): 2789.

https://doi.org/10.1182/blood.V128.22.2789.2789

Published: 2016

Journal Articles

Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Azacytidine Treatment

Roberto Latagliata, MD, Pasquale Niscola, MD, Maria Antonietta Aloe Spiriti, MD, Ida Carmosino, Laura Cesini, MD, Chiara Sarlo, MD, Annalina Piccioni, MD, Alessia Campagna, MD, Maria Lucia De Luca, Federico Vozella, Melissa Campanelli, MD, Marco Mancini, MD, Massimo Breccia, MD, Giuseppe Avvisati, MD, Agostino Tafuri, MD, Paolo de Fabritiis, MD, Giuliana Alimena, MD, Corrado Girmenia, MD

Blood (2016) 128 (22): 5544.

https://doi.org/10.1182/blood.V128.22.5544.5544

Published: 2016

Journal Articles

R-COMP Regimen in B Cell Non Hodgkin Lymphoma Patients with Cardiovascular Comorbidities

Ombretta Annibali, MDPhD, Francesca Chiodi, MD, Chiara Sarlo, MD, Natalia Cenfra, Simona Tomassini, Sergio Mecarocci, Giuseppe Cimino, MD, Giuseppe Avvisati, MD PhD

Blood (2015) 126 (23): 5096.

https://doi.org/10.1182/blood.V126.23.5096.5096

Published: 2015

Journal Articles

Allogeneic but Not Autologous Stem Cell Transplant Attenuates the Negative Prognostic Impact Dictated By Pretransplant MRD Positivity

Francesco Buccisano, MD, Luca Maurillo, MD, Maria Ilaria Del Principe, Gottardo De Angelis, MD, Raffaella Cerretti, MD, Concetta Ditto, MD, Ambra Di Veroli, MD, Alessandra Picardi, MD, Laura Cudillo, MD, Mariagiovanna Cefalo, MD, Chiara Sarlo, MD, Giorgia Fedele, MD, Marco Refrigeri, MD, Francesco Lo Coco, MD, William Arcese, MD, Sergio Amadori, Adriano Venditti

Blood (2014) 124 (21): 2363.

https://doi.org/10.1182/blood.V124.21.2363.2363

Published: 2014

Journal Articles

Age-Stratified Analysis Of The Prognostic Role Of Minimal Residual Disease Detection By Flow Cytometry, In Adult Patients With Acute Myeloid Leukemia

Francesco Buccisano, MD, Luca Maurillo, MD, Alfonso Piciocchi, PhD, Maria Ilaria Del Principe, MD, Chiara Sarlo, MD, Mariagiovanna Cefalo, MD, Concetta Ditto, MD, Ambra Di Veroli, MD, Daniela Nasso, MD, Marco Refrigeri, MD, Maria Antonietta Irno Consalvo, PhD, Daniela Fraboni, PhD, Consuelo Conti, Giovanni Del Poeta, MD, Francesco Lo Coco, MD, Sergio Amadori, Adriano Venditti, MD

Blood (2013) 122 (21): 2649.

https://doi.org/10.1182/blood.V122.21.2649.2649

Published: 2013

Journal Articles

Clinical Significance of CD69 Expression In Chronic Lymphocytic Leukemia

Giovanni Del Poeta, Maria Ilaria Del Principe, Pietro Bulian, Cristina Simotti, Francesco Buccisano, MD, Fabrizio Luciano, Antonella Zucchetto, Licia Ottaviani, Luca Maurillo, Chiara Sarlo, Annalisa Biagi, Laura Giannì, Alessio Pio Perrotti, Adriano Venditti, Paolo de Fabritiis, Valter Gattei, Sergio Amadori

Blood (2010) 116 (21): 3574.

https://doi.org/10.1182/blood.V116.21.3574.3574

Published: 2010

Journal Articles

Phase II Study of Bortezomib as a Single Agent In Patients with Relapsed/Refractory or De Novo Acute Myeloid Leukemia Unfit for Intensive Therapy

Chiara Sarlo, Maria Giovanna Cefalo, Eleonora Ceresoli, Licia Ottaviani, Selenia Campagna, Concetta Ditto, Luigi Di Caprio, Maria Ilaria Del Principe, Annibale Franchi, Luca Maurillo, MD, Francesco Buccisano, MD, Sergio Amadori, Adriano Venditti, MD

Blood (2010) 116 (21): 4360.

https://doi.org/10.1182/blood.V116.21.4360.4360

Published: 2010

Journal Articles

MRD-Directed Post-Remissional Therapy Dramatically Improves Outcome of Adult Patients with High Risk AML by Implementing Allogeneic Transplant Option

Blood (2010) 116 (21): 2702.

https://doi.org/10.1182/blood.V116.21.2702.2702

Published: 2010

Journal Articles

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

Blood (2010) 116 (13): 2295–2303.

https://doi.org/10.1182/blood-2009-12-258178

Published: 2010

Includes: Supplemental data

Journal Articles

The Amount of Spontaneous Apoptosis Is An Independent Strong Disease Progression Indicator in B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Giovanni Del Poeta, Maria Ilaria Del Principe, Francesco Buccisano, Daniela Piccioni, Luca Maurillo, Chiara Sarlo, Maria Irno Consalvo, Pietro Bulian, Antonella Zucchetto, Laura Giannì, Cristina Simotti, Paolo de Fabritiis, Adriano Venditti, Valter Gattei, Sergio Amadori

Blood (2009) 114 (22): 1252.

https://doi.org/10.1182/blood.V114.22.1252.1252

Published: 2009

Journal Articles

The Earliest Activation Marker CD69 Is An Independent and Strong Progression Indicator in B-Cell Chronic Lymphocytic Leukemia.

Giovanni Del Poeta, Maria Ilaria Del Principe, Cristina Simotti, Francesco Buccisano, Luca Maurillo, Antonella Zucchetto, Licia Ottaviani, Pietro Bulian, Chiara Sarlo, Maria Irno Consalvo, Adriano Venditti, Paolo de Fabritiis, Valter Gattei, Sergio Amadori

Blood (2009) 114 (22): 2359.

https://doi.org/10.1182/blood.V114.22.2359.2359

Published: 2009

Journal Articles

In Acute Myeloid Leukemia, the Use in Induction of Standard Dose Arac Is Associated with a Better Quality of Response as Compared to An Induction Regimen Containing High Dose Arac.

Luca Maurillo, MD, Francesco Buccisano, M.D., Alessandra Spagnoli, Maria Ilaria Del Principe, MD, Benedetta Neri, MD, Chiara Sarlo, MD, Giovanni Del Poeta, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2009) 114 (22): 1584.

https://doi.org/10.1182/blood.V114.22.1584.1584

Published: 2009

Journal Articles

Decisional Algorithm to Incorporate Hematopoietic Stem Cell Transplantation in the Management of Adult Patients with Acute Myeloid Leukaemia.

Francesco Buccisano, M.D., Luca Maurillo, Maria Ilaria Del Principe, Giovanni Del Poeta, Paola Panetta, Emanuele Ammatuna, Licia Ottaviani, Chiara Sarlo, Micol Quaresima, Gottardo De Angelis, Manuela Rizzo, Selenia Campagna, Francesco Lo Coco, William Arcese, Sergio Amadori, Adriano Venditti

Blood (2008) 112 (11): 1519.

https://doi.org/10.1182/blood.V112.11.1519.1519

Published: 2008

Journal Articles

Detection of Minimal Residual Disease by Flow-Cytometry Otimizes Risk Stratification When Combined with Cytogenetics in AML.

Francesco Buccisano, MD, Luca Maurillo, MD, Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Paola Panetta, PhD, Daniela Fraboni, PhD, Maria Irno Consalvo, PhD, Daniela Renzi, MD, Selenia Campagna, MD, Chiara Sarlo, MD, Luca Franceschini, MD, Laura Giannì, MD, Emanuele Ammatuna, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2007) 110 (11): 4242.

https://doi.org/10.1182/blood.V110.11.4242.4242

Published: 2007

NARROW

The Prognostic Value for Survival of Self-Reported Fatigue in Patients with Newly Diagnosed Myelodysplastic Syndromes: An International Prospective Observational Study By the Gimema

Clinical Relevance of Individual Response to Iron Chelation Therapy (ICT) in Patients with Myelodysplastic Syndromes (MDS) and Transfusion Requirement

Clinical Significance of Occult Central Nervous System Disease in Adult ACUTE Lymphoblastic Leukemia. a Multicenter,Report from the Campus ALL/Gimema Network

Pretreatment Health-Related Quality of Life Profile According to the EORTC QLQ-C30 in Patients with Myelodysplastic Syndromes (MDS): Analysis on 443 Lower-Risk MDS Patients

Response to Erythropoietin in Different Karyotipic Subsets of Myelodysplastic Syndromes (MDS) and MDS with Sideroblasts: Multicentric Real-Life Experience from the Grom-L Cooperative Group

Is Deferasirox Safe and Effective in Very Elderly Patients (> 75 Years) with Myelodysplastic Syndromes and Transfusional Iron Overload?

Pattern of Central Nervous System (CNS) Involvement in Adult Acute Myeloid Leukemia (AML) and Its Impact on Outcome

Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Azacytidine Treatment

R-COMP Regimen in B Cell Non Hodgkin Lymphoma Patients with Cardiovascular Comorbidities

Allogeneic but Not Autologous Stem Cell Transplant Attenuates the Negative Prognostic Impact Dictated By Pretransplant MRD Positivity

Age-Stratified Analysis Of The Prognostic Role Of Minimal Residual Disease Detection By Flow Cytometry, In Adult Patients With Acute Myeloid Leukemia

Clinical Significance of CD69 Expression In Chronic Lymphocytic Leukemia

Phase II Study of Bortezomib as a Single Agent In Patients with Relapsed/Refractory or De Novo Acute Myeloid Leukemia Unfit for Intensive Therapy

MRD-Directed Post-Remissional Therapy Dramatically Improves Outcome of Adult Patients with High Risk AML by Implementing Allogeneic Transplant Option

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

The Amount of Spontaneous Apoptosis Is An Independent Strong Disease Progression Indicator in B-Cell Chronic Lymphocytic Leukemia (B-CLL)

The Earliest Activation Marker CD69 Is An Independent and Strong Progression Indicator in B-Cell Chronic Lymphocytic Leukemia.

In Acute Myeloid Leukemia, the Use in Induction of Standard Dose Arac Is Associated with a Better Quality of Response as Compared to An Induction Regimen Containing High Dose Arac.

Decisional Algorithm to Incorporate Hematopoietic Stem Cell Transplantation in the Management of Adult Patients with Acute Myeloid Leukaemia.

Detection of Minimal Residual Disease by Flow-Cytometry Otimizes Risk Stratification When Combined with Cytogenetics in AML.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only